| Interacting proteins: Q01094 and Q00526 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: Q01094 and Q00526 |
Pubmed |
SVM Score :0.0 |
| Dominant negative cdk 3 inhibited E2F 1 , E2F 2 , and , less significantly , E2F 3 , but not E2F 4 transcription activity . ^^^ Cdk 3 bound specifically to E2F 1 / DP 1 complexes in vivo , most likely through DP 1 . ^^^ Thus , cdk 3 function contributes to the activation of E2F 1 , E2F 2 , and partially E2F 3 and , thereby , participates in the process of S phase entry . . ^^^ |
|
| Interacting proteins: Q01094 and Q00526 |
Pubmed |
SVM Score :0.0 |
| Western blot analysis of BIP with cyclins / CDKs and E2F antisera indicated association with cdc 2 , cdk 2 , cdk 4 , cyclin B , cyclin D , cyclin A and E2F 4 but not with cdk 3 , cdk 5 , cdk 6 , E2F 1 , E2F 2 , E2F 3 , E2F 5 and cyclin E . ^^^ |
|
| Interacting proteins: Q01094 and Q00526 |
Pubmed |
SVM Score :0.0 |
| Cdk 3 kinase activity is neither affected by p 16 ( in contrast to cdk4 / 6 ) nor by E2F 1 ( in contrast to cdk 2 ) , but is downregulated upon transient p 27 expression . ^^^ |
|